Cell cycle related signalling in neuro2A cells proceeds via the receptor for advanced glycation end products
Schmidt, A., Kuhla, B., Bigl, K., Münch, G., and Arendt, T. (2007) Cell cycle related signalling in neuro2A cells proceeds via the receptor for advanced glycation end products. Journal of Neural Transmission, 114 (11). pp. 1413-1424.
|PDF (Published Version) - Repository staff only - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader|
View at Publisher Website: http://dx.doi.org/10.1007/s00702-007-077...
Re-expression of cell cycle related genes such as cyclin-dependent kinases (cdk), cyclins, or cdk inhibitors in differentiated neurons in Alzheimer’s disease (AD) is rooted in aberrant mitogenic signaling. Since microglia and astroglia proliferate in the vicinity of amyloid plaques, it is likely that plaque components or factors secreted from plaque-activated glia induce mitogenic signaling in neurons. Mitogenic compounds might be S100B, overexpressed by activated astrocytes, or advanced glycation end products (AGEs), a component of plaques. Both S100B and AGEs may interact with the multiligand receptor for AGEs (RAGE) and trigger for the activation of the p42/44 mitogen-activated protein kinase (p42/44 MAPK), whether they also count for cell cycle related signaling in neurons remains unresolved. By immunohistochemical staining, we confirmed that cyclin D1 positive neurons are surrounded by AGE deposits, demonstrating the potential relevance in vivo. For exploring the mitogenic signal cascade, we used Neuro2a cells overexpressing human full-length RAGE (FL-RAGE) or the cytosolic deletion mutant (Δ-RAGE). In both cell lines, S100B and AGEs induced the production of reactive oxygen species but not in a RAGE-dependent manner. By contrast, in FL-RAGE cells but not in Δ-RAGE cells S100B and AGEs activate p42/44 MAPK, augment cyclin D1/cdk4 protein and RNA levels and the transition into the S-phase. Moreover, in FL-RAGE cells, decreased protein levels of the cdk inhibitor p16 were observed, and the p42/44 MAPK inhibitor UO126 prevented AGE and S100B stimulated cyclin D1 expression and hindered cells to enter the S-phase. Our results demonstrate that S100B and AGE may serve as mitogenic sources for the stimulation of neurons to progress through the cell cycle whereby signaling proceeds via RAGE → p42/44 MAPK → cyclin D1/cdk4.
|Item Type:||Article (Refereed Research - C1)|
|Keywords:||Alzheimer's disease; advanced glycation end products; neuro2A; S100B; AGE; p42/44 MAPK; UO126; cyclin D1; cdk 4; confocal microscopy; FACS; RT-PCR; Western blot|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1109 Neurosciences > 110999 Neurosciences not elsewhere classified @ 100%|
|SEO Codes:||92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920111 Nervous System and Disorders @ 100%|
|Deposited On:||22 Sep 2009 13:52|
|Last Modified:||18 Oct 2013 00:30|
Last 12 Months: 0
|Citation Counts with External Providers:|
Repository Staff Only: item control page